Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,630,500 | -750,400 | 98,300 | 259,100 | 183,300 |
| Depreciation Amortization | 3,901,400 | 1,322,000 | 684,800 | 472,500 | 281,900 |
| Income taxes - deferred | -690,100 | -275,000 | -221,000 | -126,900 | -118,300 |
| Accounts receivable | -611,100 | 19,100 | 371,100 | -590,900 | -57,100 |
| Other Working Capital | -431,900 | -163,600 | -80,300 | -124,400 | 88,900 |
| Other Operating Activity | 1,705,200 | 1,061,400 | -187,100 | 742,600 | 192,300 |
| Operating Cash Flow | $2,243,000 | $1,213,500 | $665,800 | $632,000 | $571,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 53,700 | -7,500 | 104,900 |
| PPE Investments | -224,900 | -170,800 | -129,500 | -120,000 | -53,900 |
| Net Acquisitions | -5,562,300 | -15,100 | -5,742,800 | -575,100 | -67,500 |
| Purchase Of Investment | -1,000 | 2,900 | -156,700 | N/A | -49,200 |
| Sale Of Investment | 453,700 | 37,700 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -36,100 | -130,000 | -9,000 | -18,700 | -10,900 |
| Other Investing Activity | -36,100 | -130,000 | 226,300 | -16,400 | -8,400 |
| Investing Cash Flow | $-5,370,600 | $-275,300 | $-5,749,000 | $-719,000 | $-74,100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 375,000 | 400,000 | N/A |
| Debt Issued | 9,356,200 | 2,437,300 | 5,665,500 | N/A | N/A |
| Debt Repayment | -6,127,000 | -3,229,500 | -679,700 | -428,800 | -459,700 |
| Common Stock Issued | 105,900 | 37,600 | 18,800 | 54,900 | 54,700 |
| Common Stock Repurchased | -130,100 | -170,000 | -16,100 | -14,200 | -6,300 |
| Other Financing Activity | -187,500 | 57,300 | -173,900 | 4,500 | 0 |
| Financing Cash Flow | $3,017,500 | $-867,300 | $5,189,600 | $16,400 | $-411,300 |
| Exchange Rate Effect | -5,900 | -23,900 | 3,300 | -2,900 | -4,200 |
| Beginning Cash Position | 329,000 | 319,000 | 209,300 | 282,800 | 201,400 |
| End Cash Position | 250,000 | 329,000 | 319,000 | 209,300 | 282,800 |
| Net Cash Flow | $-79,000 | $10,000 | $109,700 | $-73,500 | $81,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,243,000 | 1,213,500 | 665,800 | 632,000 | 571,000 |
| Capital Expenditure | -238,600 | -177,900 | -137,500 | -126,700 | -56,600 |
| Free Cash Flow | 2,004,400 | 1,035,600 | 528,300 | 505,300 | 514,400 |